T2 Biosystems, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
T2 Biosystems, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • T2 Biosystems, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 18.8M shares, a 379% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 18.8M +14.8M +379% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 17.4M -224M -92.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 5.51M -14.9M -72.9% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 4.06M +3.98M +5159% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3.92M -3.13M -44.4% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 242M +43.4M +21.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 20.4M -151M -88.1% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 77.2K -3.25M -97.7% Dec 31, 2022 10-K 2024-04-01
Q3 2022 7.05M -159M -95.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 198M +32.7M +19.7% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 171M +22.9M +15.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 3.33M -145M -97.8% Dec 31, 2021 10-K 2023-03-31
Q3 2021 166M +18M +12.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 166M +37.3M +29% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 148M +29.3M +24.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 148M +97.4M +192% Dec 31, 2020 10-K 2022-03-23
Q3 2020 148M +101M +217% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 128M +83.9M +188% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 119M +74.8M +169% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 50.7M +6.48M +14.7% Dec 31, 2019 10-K 2021-03-31
Q3 2019 46.7M +2.64M +6% Sep 30, 2019 10-Q 2019-11-18
Q2 2019 44.5M +1.06M +2.45% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 44.3M +8.32M +23.1% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 44.2M +8.23M +22.9% Dec 31, 2018 10-K 2020-03-16
Q3 2018 44M +8.24M +23% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 43.5M +12.7M +41.3% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 36M +5.43M +17.7% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 35.9M +5.47M +17.9% Dec 31, 2017 10-K 2019-03-14
Q3 2017 35.8M +5.37M +17.6% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 30.8M +6.4M +26.3% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 30.6M +6.31M +26% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 30.5M +6.31M +26.1% Dec 31, 2016 10-K 2018-03-19
Q3 2016 30.4M +10.1M +49.6% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 24.4M +4.05M +19.9% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 24.3M +4.08M +20.2% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 24.2M +4.13M +20.6% Dec 31, 2015 10-K 2017-03-15
Q3 2015 20.3M +299K +1.49% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 20.3M +18.9M +1295% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 20.2M Mar 31, 2015 10-Q 2015-05-06
Q4 2014 20M +18.6M +1319% Dec 31, 2014 10-K 2016-03-09
Q3 2014 20M Sep 30, 2014 10-Q 2014-11-05
Q2 2014 1.46M Jun 30, 2014 10-Q 2014-09-19
Q4 2013 1.41M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.